Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
312.49
-2.05 (-0.65%)
Streaming Delayed Price
Updated: 11:40 AM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
36
37
Next >
Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch
January 27, 2022
As investor appetite for high-growth stocks begins to decrease in the new year, dividend stocks will likely to gain traction in 2022.
Via
InvestorPlace
Is Amgen (AMGN) A Good Stock To Buy?
January 25, 2022
The pharmaceutical sector has a lot of big companies that pay a growing dividend, and AMGN is one of them.
Via
Talk Markets
CNBC's Final Trades: Marvell, Amgen, Viper Energy, JPMorgan And This Tech Major That Is 'Way Too Cheap'
January 25, 2022
On CNBC’s “Halftime Report Final T...
Via
Benzinga
A New Oral Therapy for Psoriasis Could Be Coming Soon
January 24, 2022
Photo by Towfiqu barbhuiya on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice...
Via
Benzinga
14 Stocks in the Healthcare Sector
January 21, 2022
Here are 14 companies in the Healthcare Sector that have investment-grade credit ratings of BBB- or better, cash flow yield of 6% or better, future total return of at least 5%.
Via
Talk Markets
Expert Ratings For Amgen
January 05, 2022
Amgen (NASDAQ:AMGN) has observed the following analyst ratings within the l...
Via
Benzinga
Expert Ratings For Amgen
December 21, 2021
Within the last quarter, Amgen (NASDAQ:AMGN) has observed the following ana...
Via
Benzinga
Amgen's Lumakras Approved In Japan For Pretreated Lung Cancer Patients
January 20, 2022
Amgen Inc's (NASDAQ: AMGN) Lumakras (sotorasib) has been approved in Japan for KRAS G12C-mutated positive, unresectable, advanced and/or recurrent non-small...
Via
Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
January 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Eisai Announces Publication Of Positive Data On Lenvima-Keytruda Combo In...
Via
Benzinga
3 Pharma Stocks Yielding Over 3%
January 18, 2022
The Pharma industry faced headwinds in 2021 as hospitals delayed procedures and elective surgeries.
Via
Talk Markets
Inflation 2022 – Week In Review
January 17, 2022
Arguably, the number one concern in 2022 for most investors, consumers, and businesses is inflation. Inflation is rising in the US and globally, and recent reports this week were not good.
Via
Talk Markets
Blue-Chip Bank Earnings, Retail Data Drag Dow Lower
January 14, 2022
Within the last hour of trading, the S&P 500 and Nasdaq managed to eke out slight gains. All three major indexes fell for the week.
Via
Talk Markets
How Is The Market Feeling About Amgen Inc?
January 13, 2022
Amgen Inc's (NASDAQ:AMGN) short percent of float has fallen 11.74% since last its last report. The company recently reported that it has 11.40 million shares sold short, which is...
Via
Benzinga
A Look Into Amgen's Price Over Earnings
January 11, 2022
Right now, Amgen Inc. (NASDAQ:AMGN) share price is at $229.33, after a 0.45% drop. Over the past month, the stock went up by 7.29%, but over the past year, it...
Via
Benzinga
Europe Approves Amgen's KRAS-Targeted Lung Cancer Therapy
January 10, 2022
The European Commission (EC) has granted conditional marketing authorization to Amgen Inc's (NASDAQ: AMGN) Lumykras (sotorasib), a KRASG12C inhibitor, for...
Via
Benzinga
2 Chamath Palihapitiya SPAC Deals Rumored: Will He Land The Year's First Deal Once Again?
January 09, 2022
The 2022 year has started quietly for SPACs, with no deals announced in the first five trading days of the year. Although two new SPAC rumors have popped up since the market...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 06, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...
Via
Benzinga
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich
Via
InvestorPlace
Financial Stocks Could be Positioned to Kick Off the Q4 Earnings Season
January 04, 2022
The U.S. dollar was rising against the Japanese yen Tuesday morning as foreign investors take notice of the jump in United States Treasury yields. The Japanese yen is now trading...
Via
Benzinga
Dogs Of The Dow Performance Does Not Keep Pace In 2021
January 01, 2022
In this past year, the 'Dogs of the Dow' strategy did not keep pace with either the Dow Jones Index or the S&P 500 Index. The Dow Dogs generated a total return of 16.3% versus 20.8% for the DJIA and...
Via
Talk Markets
Dogs of Major Indices
December 30, 2021
As we approach the end of 2021, we take a look at the ten Dow stocks that would currently make up the Dogs of the Dow for 2022.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022
January 05, 2022
Upgrades According to TD Securities, the prior rating for Canada Goose Holdings Inc (NYSE:
Via
Benzinga
These 8 Dow Jones Stocks Are Negative For 2021
December 30, 2021
The Dow Jones Industrial Average is a price-weighted index consisting of 30 stocks. It's one of the oldest and best-known measures of stock market performance. The blue-...
Via
Benzinga
Best Stocks For Wheel Strategy Trades: Use These In 2022
December 26, 2021
Blue chips companies, high dividend stocks, REITs, and low beta ETFs work well when employing the wheel strategy.
Via
Talk Markets
BAD ETF: The Top “Sin Stock” Holdings in the New Anti-ESG Fund That Debuts Today
December 22, 2021
There's a new ETF on the block from BAD Investment Company and it seeks to offer investments in sin stocks for interested traders.
Via
InvestorPlace
Amgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level
December 21, 2021
The FDA has approved Amgen Inc's (NASDAQ: AMGN) Otezla (apremilast) to treat adult patients with plaque psoriasis who are candidates for phototherapy or...
Via
Benzinga
Synthetic Biology Platform Senti Bio Rides On Omid Farokhzad's SPAC For NASDAQ Debut
December 20, 2021
Senti Biosciences Inc, the synthetic biology play helmed by MIT whiz Tim Lu, will be merging with Farokhzad's Dynamics Special Purpose Corp (NASDAQ: DYNS) in a ...
Via
Benzinga
AstraZeneca - Amgen's Tezspire Biologic Scores FDA Approval For Severe Asthma
December 20, 2021
The FDA has approved AstraZeneca plc (NASDAQ: AZN) / Amgen Inc's (NASDAQ: AMGN) Tezspire (tezepelumab-ekko) as add-on maintenance treatment of adult...
Via
Benzinga
The Week Ahead In Biotech (Dec. 19-25): Key Events Of Holiday-Shortened Week
December 19, 2021
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also drew strength from some...
Via
Talk Markets
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week
December 19, 2021
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also...
Via
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
36
37
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.